Yasuhiro Miki

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications

"Is the Spanish Flu a Forgotten Pandemic?" A Survey during the COVID-19 Pandemic.

"Is the Spanish Flu a Forgotten Pandemic?" A Survey during the COVID-19 Pandemic.

Journal: The Tohoku journal of experimental medicine
Published: June 03, 2026

T-Cell Immunoglobulin and Mucin Domain 1 (Tim1) as a Prognostic Factor Associated With Therapeutic Resistance in Human Breast Carcinoma.

T-Cell Immunoglobulin and Mucin Domain 1 (Tim1) as a Prognostic Factor Associated With Therapeutic Resistance in Human Breast Carcinoma.

Journal: International journal of breast cancer
Published: October 21, 2025

HER2 Interactome Profiling Reveals MARCKS as a Candidate Marker Associated with Aggressive Breast Cancer.

HER2 Interactome Profiling Reveals MARCKS as a Candidate Marker Associated with Aggressive Breast Cancer.

Journal: Cancers
Published: July 31, 2025

Cancer-associated fibroblast marker signatures and stromal composition in usual interstitial pneumonia-associated lung adenocarcinoma: an analysis using a proteomic-immunohistochemical approach.

Cancer-associated fibroblast marker signatures and stromal composition in usual interstitial pneumonia-associated lung adenocarcinoma: an analysis using a proteomic-immunohistochemical approach.

Journal: Virchows Archiv : an international journal of pathology
Published: June 03, 2025

NRF2-dependent suppression of selenoprotein P expression promotes intracellular selenium metabolic remodeling and upregulation of antioxidant selenoproteins in hepatocellular carcinoma.

NRF2-dependent suppression of selenoprotein P expression promotes intracellular selenium metabolic remodeling and upregulation of antioxidant selenoproteins in hepatocellular carcinoma.

Journal: Redox biology
Published: May 20, 2025

Detection of Somatostatin Receptors by Ligand Derivative Staining in Breast Tumors.

Detection of Somatostatin Receptors by Ligand Derivative Staining in Breast Tumors.

Journal: Anticancer research
Published: April 23, 2025

5α-reductase type 3 is a predictive marker for chemotherapy efficacy in breast cancer in an androgen-independent manner.

5α-reductase type 3 is a predictive marker for chemotherapy efficacy in breast cancer in an androgen-independent manner.

Journal: The Journal of steroid biochemistry and molecular biology
Published: April 01, 2025

Discoidin Domain Receptor 2 (DDR2) Promotes Prostate Cancer Progression in Cooperation with Collagen Remodeling.

Discoidin Domain Receptor 2 (DDR2) Promotes Prostate Cancer Progression in Cooperation with Collagen Remodeling.

Journal: Acta histochemica et cytochemica
Published: February 07, 2025

Integrin β5-positive cancer-associated fibroblasts promoting lung adenocarcinoma invasion leading to poor prognosis.

Integrin β5-positive cancer-associated fibroblasts promoting lung adenocarcinoma invasion leading to poor prognosis.

Journal: Pathology, research and practice
Published: January 14, 2025

Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I.

Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I.

Journal: Cancers
Published: December 12, 2024

Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance.

Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance.

Journal: Cancers
Published: October 02, 2024

Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer.

Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer.

Journal: Breast cancer (Tokyo, Japan)
Published: September 27, 2024
Showing 1-12 of 155

Last Updated: 09/26/2026